NCT00791388View on ClinicalTrials.gov

Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Healthy
Interventions
DRUG

Placebo

oral capsule, 2x/day for 14 days

DRUG

PG-760564

oral capsule, 50 mg, 2x/day for 14 days

DRUG

PG-760564

oral capsule, 100mg, 2x/day for 14 days

DRUG

PG-760564

oral capsule, 200 mg, 2x/day for 14 days

DRUG

PG-760564

oral capsule, 400 mg, 2x/day for 14 days

Trial Locations (1)

33126

Stuart I Harris, MD, PhD, Miami

All Listed Sponsors
lead

Procter and Gamble

INDUSTRY

NCT00791388 - Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days | Biotech Hunter | Biotech Hunter